Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Stefan Peinert"'
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 2 (2010)
Synchronous or metachronous colorectal liver metastases (CLMs), although being the expression of systemic disease, allow a curative approach for about 25—35% of patients. Patients presenting with CLMs should receive a multimodal management in order
Externí odkaz:
https://doaj.org/article/70f4d11d002847cfba76c18093bdd01d
Autor:
Stefan Peinert, Wilfried Grothe, Alexander Stein, Lutz P. Müller, Joern Ruessel, Wieland Voigt, Hans-Joachim Schmoll, Dirk Arnold
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 2 (2010)
Background: Standard chemotherapy for patients with metastatic colorectal cancer (mCRC) or gastric cancer (GC) consists of two-drug, usually fluoropyrimidine-based, combinations, with or without the addition of biological agents. Studies of triple-dr
Externí odkaz:
https://doaj.org/article/4532357e7bb64553a31c4ee617541054
Autor:
Phillip K. Darcy, Paul J Neeson, David Westerman, Tsin Yee Tai, Stefan Peinert, Jennifer A. Westwood, Mandy Shin, Dominic M. Wall, Peter Gambell, Javier Haurat, Andrew M. Scott, Amit Khot, Karen Chen, Mark J. Smyth, Dirk Hönemann, Lucy Kravets, Michael Dickinson, Michael H. Kershaw, H. Miles Prince, Kellie M. Tainton, Joseph A. Trapani, David Ritchie
Publikováno v:
Molecular Therapy. 21(11):2122-2129
In a phase I study of autologous chimeric antigen receptor (CAR) anti-LeY T-cell therapy of acute myeloid leukemia (AML), we examined the safety and postinfusion persistence of adoptively transferred T cells. Following fludarabine-containing precondi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e458ed06e998037578e0f83efafe2bfc
Autor:
John F. Seymour, Stefan Peinert
Publikováno v:
Leukemia & Lymphoma. 51:1767-1770
Waldenstrom macroglobulinemia (WM) is an un- common clinico-pathological syndromic manifesta- tion of lymphoplasmacytic lymphoma. In the more common sub-types of non-Hodgkin lymphoma (NHL) there are internationally accepted robust and reproducible re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc2cd3879cec01599d5931d6e6371ccc
https://doi.org/10.3109/10428194.2010.509455
https://doi.org/10.3109/10428194.2010.509455
Publikováno v:
Immunotherapy. 1:905-912
905 ISSN 1750-743X Immunotherapy (2009) 1(6), 905–912 10.2217/IMT.09.69 © 2009 Future Medicine Ltd “...armed with the ‘second generation’ of chimeric TCRs and a better understanding of how to optimize T‐cell persistence following infusion,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba789d3fad82a349f7fc072a2ef5c290
https://doi.org/10.2217/imt.09.69
https://doi.org/10.2217/imt.09.69
Autor:
Michael Michael, Mark J. Smyth, Melanie Trivett, William K. Murray, Benjamin Solomon, David Ball, Joseph A. Trapani, Nicole M. Haynes, Andrew M. Scott, Michael H. Kershaw, Linda Mileshkin, Jennifer A. Westwood, Dirk Hönemann, Angela C. Burman, Stefan Peinert, Preethi Mayura-Guru, Phillip K. Darcy, H. Miles Prince
Publikováno v:
Journal of Immunotherapy. 32:292-301
In this study we aimed to determine the suitability of the Lewis-Y carbohydrate antigen as a target for immunotherapy using genetically redirected T cells. Using the 3S193 monoclonal antibody and immunohistochemistry, Lewis-Y was found to be expresse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e526e664a76421c9226e3f29405cc61e
https://doi.org/10.1097/cji.0b013e31819b7c8e
https://doi.org/10.1097/cji.0b013e31819b7c8e
Autor:
Dieter K. Hossfeld, Susanna Hegewisch-Becker, Klaus Kühlcke, Axel R. Zander, Wolfram Ostertag, Stefan Peinert, Christopher Baum, Eckert Hg, Alexander Carpinteiro
Publikováno v:
International Journal of Cancer. 98:785-792
This study was undertaken to analyze the hematotoxicity of paclitaxel (Taxol) and to test whether transduction of repopulating hematopoietic cells with a retroviral vector (SF1m) expressing the human multidrug resistance 1 gene (MDR1) would permit do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f68754601c7a21ba1eabc2a98aed87e
https://doi.org/10.1002/ijc.10206
https://doi.org/10.1002/ijc.10206
Publikováno v:
Leukemia & Lymphoma. 50:303-305
Rituximab is a chimeric mouse–human anti-CD20 monoclonal antibody registered in many countries for intravenous administration. When used as a single agent or in combination with chemotherapy (as ei...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dc76950bb05dc0a9eee270ba9e26ded
https://doi.org/10.1080/10428190802617805
https://doi.org/10.1080/10428190802617805
Autor:
Hans-Joachim Schmoll, J. Ruessel, Alexander Stein, Wieland Voigt, Dirk Arnold, Wilfried Grothe, Stefan Peinert, Lutz P. Müller
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 2 (2010)
Background: Standard chemotherapy for patients with metastatic colorectal cancer (mCRC) or gastric cancer (GC) consists of two-drug, usually fluoropyrimidine-based, combinations, with or without the addition of biological agents. Studies of triple-dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1cbcaf065e06aaf46b39e2f5bc882ef
https://pubmed.ncbi.nlm.nih.gov/21789132
https://pubmed.ncbi.nlm.nih.gov/21789132
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 2 (2010)
Synchronous or metachronous colorectal liver metastases (CLMs), although being the expression of systemic disease, allow a curative approach for about 25—35% of patients. Patients presenting with CLMs should receive a multimodal management in order
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bbbf5f802f937fc346aec08600b17f3
https://doaj.org/article/70f4d11d002847cfba76c18093bdd01d
https://doaj.org/article/70f4d11d002847cfba76c18093bdd01d